BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/23/2026 8:27:35 AM | Browse: 1 | Download: 0
| Category |
Immunology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Radiotherapy-free neoadjuvant strategy using sintilimab plus XELOX in locally advanced rectal cancer: A single-arm phase II trial
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei-Dong Qiang, Qi Wei, Bo Yang, Wan-Jing Chen, Chang-Qing Lin and Yong-Xiang Li |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82372646 |
|
| Corresponding Author |
Yong-Xiang Li, PhD, Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Shushan District, Hefei 230022, Anhui Province, China. liyongxiang@ahmu.edu.cn |
| Key Words |
Locally advanced rectal cancer; Immunotherapy; Sintilimab; Radiotherapy-free; Pathological complete response |
| Core Tip |
This phase II single-arm study evaluated a radiotherapy-free neoadjuvant strategy using sintilimab plus XELOX in patients with locally advanced rectal cancer without mesorectal fascia involvement. The regimen achieved favorable pathological responses with acceptable toxicity. Tumor size > 4 cm and elevated baseline carcinoembryonic antigen levels were associated with a lower likelihood of major pathological response. Exploratory immune microenvironment analysis suggested a potential association between CD8+ T-cell infiltration and treatment response. These findings support further investigation of radiotherapy-sparing strategies in carefully selected patients. |
| Citation |
Qiang WD, Wei Q, Yang B, Chen WJ, Lin CQ, Li YX. Radiotherapy-free neoadjuvant strategy using sintilimab plus XELOX in locally advanced rectal cancer: A single-arm phase II trial. World J Gastroenterol 2026; In press |
 |
Received |
|
2025-12-22 03:07 |
 |
Peer-Review Started |
|
2025-12-22 03:07 |
 |
First Decision by Editorial Office Director |
|
2026-01-20 09:27 |
 |
Return for Revision |
|
2026-01-20 09:27 |
 |
Revised |
|
2026-01-30 05:43 |
 |
Publication Fee Transferred |
|
2026-02-03 03:29 |
 |
Second Decision by Editor |
|
2026-03-23 02:44 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-23 08:27 |
 |
Articles in Press |
|
2026-03-23 08:27 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345